Severe edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase-4 inhibitor

被引：0
|
作者：
Maita, Hiroki [1 ]
Kobayashi, Tadashi [2 ]
Akimoto, Takashi [2 ]
Osawa, Hiroshi [2 ]
Kato, Hiroyuki [1 ,2 ,3 ]
机构：
[1] Hirosaki Univ, Dev Community Healthcare, Grad Sch Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Dept Gen Med, Sch Med Hosp, Aomori, Japan
[3] Hirosaki Univ, Gen Med, Grad Sch Med, Aomori, Japan
来源：
JOURNAL OF GENERAL AND FAMILY MEDICINE | 2022年 / 23卷 / 02期
关键词：
blister; dipeptidyl peptidase-4 inhibitor; edema; sitagliptin;
D O I：
10.1002/jgf2.502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [31] The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice
    Yorifuji, Naoki
    Inoue, Takuya
    Iguchi, Munetaka
    Fujiwara, Kaori
    Kakimoto, Kazuki
    Nouda, Sadaharu
    Okada, Toshihiko
    Kawakami, Ken
    Abe, Yosuke
    Takeuchi, Toshihisa
    Higuchi, Kazuhide
    ONCOLOGY REPORTS, 2016, 35 (02) : 676 - 682
  • [32] New Synthetic Route to a Dipeptidyl Peptidase-4 Inhibitor
    Lafrance, Danny
    Caron, Stephane
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (03) : 409 - 414
  • [33] The Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Suppresses Mouse Colon Tumorigenesis in Type 2 Diabetes Mice
    Yorifuji, Naoki
    Inoue, Takuya
    Fujiwara, Kaori
    Iguchi, Munetaka
    Kojima, Yuichi
    Okada, Toshihiko
    Kakimoto, Kazuki
    Nouda, Sadaharu
    Kawakami, Ken
    Abe, Yosuke
    Takeuchi, Toshihisa
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2015, 148 (04) : S577 - S577
  • [34] Vildagliptin:: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties
    Ahrén, B
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (04) : 431 - 442
  • [35] Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs
    Beconi, Maria G.
    Reed, James R.
    Teffera, Yohannes
    Xia, Yuan-Qing
    Kochansky, Christopher J.
    Liu, David Q.
    Xu, Shiyao
    Elmore, Charles S.
    Ciccotto, Suzanne
    Hora, Donald F.
    Stearns, Ralph A.
    Vincent, Stella H.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (04) : 525 - 532
  • [36] Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: Focus on sitagliptin
    Herman, G. A.
    Stein, P. P.
    Thornberry, N. A.
    Wagner, J. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) : 761 - 767
  • [37] The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates retinal endothelial cell dysfunction triggered by inflammation
    Goncalves, Andreia
    Almeida, Luisa
    Silva, Ana Paula
    Fontes-Ribeiro, Carlos
    Ambrosio, Antonio F.
    Cristovao, Armando
    Fernandes, Rosa
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 : 833 - 838
  • [38] Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes
    Nomiyama, Takashi
    Akehi, Yuko
    Takenoshita, Hiromasa
    Nagaishi, Ryoko
    Terawaki, Yuichi
    Nagasako, Hisahiro
    Kudo, Tadachika
    Kodera, Takehiko
    Kobayashi, Kunihisa
    Urata, Hidenori
    Yanase, Toshihiko
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 95 (02) : E27 - E28
  • [39] Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells
    Komatsu, Tomohiro
    Abe, Satomi
    Nakashima, Shihoko
    Sasaki, Kei
    Higaki, Yasuki
    Saku, Keijiro
    Miura, Shin-ichiro
    Uehara, Yoshinari
    BIOMOLECULES, 2023, 13 (02)
  • [40] Single-Dose Pharmacokinetics and Pharmacodynamics of Sitagliptin, an Inhibitor of Dipeptidyl Peptidase-4, in Healthy Indian Male Subjects
    Sangle, Ganesh V.
    Patil, Mohan
    Deshmukh, Nitin
    Kamble, Shantibhushan
    Vuppalavanchu, Kiran Kumar
    Kale, Sushil
    Baig, Layeeq
    Singh, Geetchandra
    Shaikh, Javed
    Tripathi, Jitendra
    Aravindababu, P.
    DIABETES, 2017, 66 : A630 - A630
12345